Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 21, Issue 6, 1998, Pages 591-595

  Bilgrami, S ^a   Feingold, J M ^a   Dorsky, D ^a   Edwards, R L ^a   Clive, J ^a   Tutschka, P J ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Autologous stem cell transplantation; Streptococcus viridans

Indexed keywords

AMPICILLIN; BUSULFAN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; THIOTEPA;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; AUTOTRANSPLANTATION; BACTEREMIA; CHILD; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE MYELOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; OVARY CARCINOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; STEM CELL TRANSPLANTATION; STREPTOCOCCUS MITIS; STREPTOCOCCUS SANGUINIS; TREATMENT OUTCOME;

EID: 0031907995     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701140     Document Type: Article

References (33)

1. Villablanca JG, Steiner M, Kersey J et al. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients. Bone Marrow Transplant 1990; 6: 387-393.
2. Steiner M, Villablanca J, Kersey J et al. Alpha-streptococcal shock in bone marrow transplantation patients. Am J Hematol 1993; 42: 354-358.
3. Rozenberg-Arska M, Dekker AW, Verhoef J. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. J Infect Dis 1985; 152: 104-107.
4. Maschmeyer G, Haralambie E, Gaus W et al. Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia. Infection 1988; 16: 98-104.
5. Lew MA, Kehoe K, Ritz J et al. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J Clin Oncol 1995; 13: 239-250.
6. Schmeiser T, Eberhard K, Arnold R et al. Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation. Scand J Infect Dis 1988; 20: 625-631.
7. Lew MA, Kehoe K, Ritz J et al. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation. Transplantation 1991; 51: 630-636.
8. Cohen J, Worsley AM, Goldman JM et al. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 1983; 2: 1452-1454.
9. Ringden O, Heimdahl A, Lonnquist B et al. Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acylovir. Lancet 1984; 1: 744.
10. Menichetti F, Felicini R, Bucaneve G et al. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant 1989; 4: 489-492.
11. DePauw BE, Donnelly JP, DeWitte T et al. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1990; 5: 179-182.
12. Mascret B, Maraninchi D, Gastaut JA et al. Risk factors for streptococcal septicaemia after marrow transplantation. Lancet 1984; 1: 1185-1186.
13. Classen DC, Burke JP, Ford CD et al. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am J Med 1990; 89: 441-446.
14. Martino R, Mantiega R, Sanchez I et al. Viridans streptococcal shock syndrome during bone marrow transplantation. Acta Haematol 1995; 94: 69-73.
15. Engelhard D, Elishoov H, Or R et al. Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study. Bone Marrow Transplant 1995; 16: 565-570.
16. Kilian M, Reinholdt J, Nyvad B et al. IgA1 proteases of oral streptococci: ecological aspects. Immunol Invest 1989; 18: 161-170.
17. Cruciani M, Rampazzo R, Malena M et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis 1996; 23: 795-806.
18. Wimperis JZ, Baglin TP, Marcus RE et al. The assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts. Bone Marrow Transplant 1991; 8: 363-367.
19. Dekker AW, Verdonck LF, Rozenberg-Arska M. Infection prevention in autologous bone marrow transplantation and the role of protective isolation. Bone Marrow Transplant 1994; 14: 89-93.
20. Kern WV, Hay B, Kern P et al. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. Antimicrob Agents Chemother 1994; 38: 465-472.
21. Broun ER, Wheat JL, Kneebone PH et al. Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation. Antimicrob Agents Chemother 1994; 38: 576-579.
22. Gluckman E, Roudet C, Hirsch I et al. Prophylaxis of bacterial infections after bone marrow transplantation. A randomized prospective study comparing oral broad-spectrum non-absorbable antibiotics (vancomycin-tobramycin-colistin) to absorbable antibiotics (ofloxacin-amoxicillin). Chemotherapy 1991; 37 (Suppl. 1): 33-38.
23. Gilbert C, Meisenberg B, Vredenburgh J et al. Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. J Clin Oncol 1994; 12: 1005-1011.
24. Attal M, Schlaifer D, Rubie H et al. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial. J Clin Oncol 1991; 9: 865-870.
25. Quinn JP, DiVincenzo CA, Lucks DA et al. Serious infections due to penicillin-resistant strains of viridans streptococci with altered penicillin-binding proteins. J Infect Dis 1988; 157-764-769.
26. Rolston KVI, Elting LS, Bodey GP. Bacteremia due to virdians streptococci in neutropenic patients. Am J Med 1995; 99: 450.
27. Bochud P-Y, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 1994; 97: 256-264.
28. Bostrom B, Weisdorf D. Mucositis and alpha-streptococcal sepsis in bone marrow transplant recipients. Lancet 1994; 1: 1120-1121.
29. Valteau D, Hartmann O, Brugieres L et al. Streptococcal septicemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy. Bone Marrow Transplant 1991; 7: 415-419.
30. Henslee J, Bostrom B, Weisdorf D et al. Streptococcal sepsis in bone marrow transplant patients. Lancet 1984; 1: 393.
31. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992; 14: 1201-1207.
32. Rozenberg-Arska M, Dekker A, Verdonck L et al. Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin. Infection 1989; 17: 240-244.
33. Bow EJ, Mandell LA, Louie TJ et al. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. Ann Intern Med 1996; 125: 183-190.